NYSE:TEVA
Teva Pharmaceutical Industries Limited Stock News
$14.05
-0.0500 (-0.355%)
At Close: Apr 30, 2024
Teva Update
10:51am, Saturday, 14'th Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - Nove
Teva Shareholder Notice
08:55pm, Wednesday, 11'th Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - Nove
New York, New York--(Newsfile Corp. - November 11, 2020) - Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE:
Teva Shareholder Alert
08:54pm, Tuesday, 10'th Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - Nove
Teva Class Action Reminder
10:34am, Sunday, 08'th Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - Nove
New York, New York--(Newsfile Corp. - November 7, 2020) - Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE
Teva Shareholder Notice
10:14am, Saturday, 07'th Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - Nove
Teva Shareholder Alert
09:02pm, Thursday, 05'th Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - Nove
Teva Pharmaceutical Industries Ltd (TEVA) CEO Kare Schultz on Q3 2020 Results - Earnings Call Transcript
04:47pm, Thursday, 05'th Nov 2020
Teva Pharmaceutical Industries Ltd (TEVA) CEO Kare Schultz on Q3 2020 Results - Earnings Call Transcript
Generic Pharma Behemoth Skids As Earnings Stall, Sales Lag Forecasts
09:05am, Thursday, 05'th Nov 2020
Early Thursday, Teva Pharmaceutical reported adjusted earnings of 58 cents per share on $3.98 billion in sales for its third quarter ended Sept. 30. In response, Teva stock slipped.
TEVA DEADLINE ALERT
08:55pm, Wednesday, 04'th Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - Nove
Teva Deadline Alert
08:33pm, Monday, 02'nd Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - Nove
Miller Value Partners is Betting on Teva Pharmaceutical Industries (TEVA) Stock
11:10am, Monday, 02'nd Nov 2020
Miller Value Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here. The Opportunity Equity Fund posted a return of 13.01% for the quarter (net of fees), outperf
NEW YORK, Oct. 30, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE: TEVA) between Octo
New York, New York--(Newsfile Corp. - October 28, 2020) - Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE
